Jayne B. Hart - Mar 1, 2023 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Officer
Signature
By: Justin Hunter For: Jayne B. Hart
Stock symbol
MYGN
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 03:06 PM
Previous filing
Oct 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MYGN Common Stock 173K Mar 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jayne B. Hart is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The holdings for the Reporting Person include one additional share that was acquired on November 30, 2022 under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief People Officer, effective March 1, 2023, and therefore is no longer subject to Section 16 reporting.